2-223765159-C-CCAT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001039569.2(AP1S3):c.429+53_429+54insATG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0935 in 1,529,558 control chromosomes in the GnomAD database, including 16,098 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.22 ( 6552 hom., cov: 0)
Exomes 𝑓: 0.080 ( 9546 hom. )
Consequence
AP1S3
NM_001039569.2 intron
NM_001039569.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.488
Genes affected
AP1S3 (HGNC:18971): (adaptor related protein complex 1 subunit sigma 3) This gene encodes a member of the adaptor-related protein complex 1, sigma subunit genes. The encoded protein is a component of adaptor protein complex 1 (AP-1), one of the AP complexes involved in claathrin-mediated vesicular transport from the Golgi or endosomes. Disruption of the pathway for display of HIV-1 antigens, which prevents recognition of the virus by cytotoxic T cells, has been shown to involve the AP-1 complex (PMID: 15569716). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-223765159-C-CCAT is Benign according to our data. Variant chr2-223765159-C-CCAT is described in ClinVar as [Benign]. Clinvar id is 2628211.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.509 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AP1S3 | NM_001039569.2 | c.429+53_429+54insATG | intron_variant | ENST00000396654.7 | |||
AP1S3 | XM_011510600.4 | c.292-6410_292-6409insATG | intron_variant | ||||
AP1S3 | NR_110905.2 | n.600+53_600+54insATG | intron_variant, non_coding_transcript_variant | ||||
AP1S3 | NR_110906.2 | n.452+53_452+54insATG | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AP1S3 | ENST00000396654.7 | c.429+53_429+54insATG | intron_variant | 2 | NM_001039569.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.216 AC: 32544AN: 150776Hom.: 6536 Cov.: 0
GnomAD3 genomes
AF:
AC:
32544
AN:
150776
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.129 AC: 25962AN: 201824Hom.: 2734 AF XY: 0.117 AC XY: 12896AN XY: 109964
GnomAD3 exomes
AF:
AC:
25962
AN:
201824
Hom.:
AF XY:
AC XY:
12896
AN XY:
109964
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0801 AC: 110442AN: 1378662Hom.: 9546 Cov.: 32 AF XY: 0.0804 AC XY: 55119AN XY: 685164
GnomAD4 exome
AF:
AC:
110442
AN:
1378662
Hom.:
Cov.:
32
AF XY:
AC XY:
55119
AN XY:
685164
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.216 AC: 32602AN: 150896Hom.: 6552 Cov.: 0 AF XY: 0.220 AC XY: 16202AN XY: 73678
GnomAD4 genome
AF:
AC:
32602
AN:
150896
Hom.:
Cov.:
0
AF XY:
AC XY:
16202
AN XY:
73678
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 40% of patients studied by a panel of primary immunodeficiencies. Number of patients: 38. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at